367-02-015 ISMRM Abstract

A Melanin-Based Bimetallic Nanozyme for MRI-Guided Thermo-Chemodynamic Combination Therapy against Glioblastoma

Primary: Preclinical Animal & in vitro MR - Probes & Targets

Secondary: Preclinical Animal & in vitro MR - Small Animals

367-02-015 · Cancer Detection and Therapies · Monday, 11 May, 9:15 AM–10:10 AM · Digital Posters Row H

Keywords: Magnetic resonance imaging Melanin Nanoparticle Glioblastoma Multiforme Bimetallic nanozyme

Accepted

Yuyang Yao ¹, Ying Shi¹, jianxiu lian², Yue Liu¹, Pengfei Liu¹

¹Department of Magnetic Resonance, The First Affiliated Hospital of Harbin Medical University, Harbin, China

²Philips Healthcare (Beijing), Beijing, China

Presenting Author: Yuyang Yao

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Alexander BM, Cloughesy TF: Adult Glioblastoma. J Clin Oncol 2017, 35(21):2402-2409.PMID: 28640706 DOI: 10.1200/JCO.2017.73.0119 [doi] [pmid]

2. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL: Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 2014, 23(10):1985-1996.PMID: 25053711 PMCID: PMC4185005 DOI: 10.1158/1055-9965.EPI-14-0275 [doi] [pmid]

3. Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M: Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 2020, 70(4):299-312.PMID: 32478924 DOI: 10.3322/caac.21613 [doi] [pmid]

4. Singh S, Dey D, Barik D, Mohapatra I, Kim S, Sharma M, Prasad S, Wang P, Singh A, Singh G: Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct Target Ther 2025, 10(1):213.PMID: 40628732 PMCID: PMC12238593 DOI: 10.1038/s41392-025-02299-4 [doi] [pmid]

5. Chen Y, Liu P, Sun P, Jiang J, Zhu Y, Dong T, Cui Y, Tian Y, An T, Zhang J et al: Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme. Theranostics 2019, 9(5):1453-1473.PMID: 30867843 PMCID: PMC6401508 DOI: 10.7150/thno.29987 [doi] [pmid]

6. Chen A, Sun J, Liu S, Li L, Peng X, Ma L, Zhang R: The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents. Biomater Sci 2020, 8(1):379-390.PMID: 31728481 DOI: 10.1039/c9bm01580a [doi] [pmid]

7. Meng T, Fan B, Li Q, Peng X, Xu J, Zhang R: Matrix metalloproteinase-initiated aggregation of melanin nanoparticles as highly efficient contrast agent for enhanced tumor accumulation and dual-modal imaging. J Mater Chem B 2020, 8(43):9888-9898.PMID: 33034320 DOI: 10.1039/d0tb01651a [doi] [pmid]

8. Tan M, Ye Z, Jeong EK, Wu X, Parker DL, Lu ZR: Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents. Bioconjug Chem 2011, 22(5):931-937.PMID: 21473650 PMCID: PMC3541050 DOI: 10.1021/bc100573t [doi] [pmid]

9. Ullah Z, Abbas Y, Gu J, Ko Soe S, Roy S, Peng T, Guo B: Chemodynamic Therapy of Glioblastoma Multiforme and Perspectives. Pharmaceutics 2024, 16(7).PMID: 39065639 PMCID: PMC11280080 DOI: 10.3390/pharmaceutics16070942 [doi] [pmid]

10. Fan Q, Cheng K, Hu X, Ma X, Zhang R, Yang M, Lu X, Xing L, Huang W, Gambhir SS et al: Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc 2014, 136(43):15185-15194.PMID: 25292385 PMCID: PMC4227813 DOI: 10.1021/ja505412p [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/367-02-015